Water Quality in AUBURN, PA (17922)
EPA violation data for public water systems serving ZIP code 17922.
450
Total Violations
17
Health-Based
433
Monitoring / Reporting
437
Resolved
What does this mean?
437 of 450 violations have been resolved. 17 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 433 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Violations Detail (450 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 21, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | Increased risk of cancer |
| Bromate | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | Increased risk of cancer |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 22, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 22, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 22, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 22, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Increased risk of cancer |
| Bromate | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Increased risk of cancer |
| Bromate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Increased risk of cancer |
| Bromate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 20, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 20, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 20, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 20, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 20, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 20, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 20, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2024 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Bromate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Kidney damage |
| Barium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increase in blood pressure |
| Barium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increase in blood pressure |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Allergic dermatitis |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Asbestos | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Asbestos | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Kidney damage |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Nerve damage or thyroid problems |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Allergic dermatitis |
| E. COLI | Monitoring | 0 | N/A | Dec 23, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 23, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 23, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 23, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 23, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Bromate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Bromate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Allergic dermatitis |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Kidney damage |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Kidney damage |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Nerve damage or thyroid problems |
| Asbestos | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Asbestos | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Bromate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Bromate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Allergic dermatitis |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Barium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increase in blood pressure |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Barium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increase in blood pressure |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Bromate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Endothall | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Nerve damage or thyroid problems |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Nerve damage or thyroid problems |
| Endothall | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Barium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increase in blood pressure |
| Barium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increase in blood pressure |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Asbestos | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Cardiovascular system or reproductive problems |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Allergic dermatitis |
| Asbestos | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 20, 2021 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 20, 2021 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Sep 18, 2021 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Sep 10, 2021 | Active | N/A |
| Chlorine | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 21, 2021 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 8, 2021 | Active | N/A |
| Chlorine | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 11, 2021 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 11, 2021 | Active | N/A |
| Bromate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | May 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | May 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | May 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | May 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | May 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | May 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Bromate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 1, 2021 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(31)
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Bromate
27
Bromate
27
TTHM
27
TTHM
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
4F
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2024(50)
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
4F
Revised Total Coliform Rule
4F
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Public Notice
75
Public Notice
75
Public Notice
75
2023(109)
Nitrite
03
1,2-Dichloropropane
03
Xylenes, Total
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
Ethylbenzene
03
Ethylbenzene
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
Bromate
27
Bromate
27
1,2-Dichloroethane
03
1,2-Dichloroethane
03
Trichloroethylene
03
Trichloroethylene
03
Toluene
03
Toluene
03
Arsenic
03
Arsenic
03
Mercury
03
Mercury
03
Barium
03
Barium
03
Carbon tetrachloride
03
Nitrite
03
Antimony, Total
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
CHLOROBENZENE
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
Selenium
03
Selenium
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
Styrene
03
Styrene
03
Antimony, Total
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
Nickel
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
CHLOROBENZENE
03
1,2-Dichloropropane
03
Chromium
03
Xylenes, Total
03
Asbestos
03
Benzene
03
Benzene
03
Asbestos
03
Thallium, Total
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
Thallium, Total
03
Beryllium, Total
03
Carbon tetrachloride
03
Beryllium, Total
03
Cadmium
03
Cadmium
03
CYANIDE
03
CYANIDE
03
Fluoride
03
Fluoride
03
Nitrate
03
Nitrate
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Nickel
03
Chromium
03
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2022(90)
Nickel
03
Chromium
03
Styrene
03
Fluoride
03
Cadmium
03
Cadmium
03
Benzene
03
Tetrachloroethylene
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Fluoride
03
Antimony, Total
03
Tetrachloroethylene
03
Carbon tetrachloride
03
Ethylbenzene
03
Ethylbenzene
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
Styrene
03
Mercury
03
Mercury
03
Carbon tetrachloride
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
CYANIDE
03
CYANIDE
03
Asbestos
03
Asbestos
03
Antimony, Total
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
Nitrite
03
Nitrite
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Nitrate
03
Nitrate
03
Bromate
27
Bromate
27
Chromium
03
Nickel
03
Selenium
03
Selenium
03
Trichloroethylene
03
Trichloroethylene
03
Arsenic
03
Arsenic
03
Barium
03
Beryllium, Total
03
Beryllium, Total
03
o-Dichlorobenzene
03
Thallium, Total
03
Thallium, Total
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
Xylenes, Total
03
Xylenes, Total
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
Benzene
03
1,2-Dichloroethane
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
Toluene
03
Toluene
03
o-Dichlorobenzene
03
Barium
03
1,2-Dichloroethane
03
Surface Water Treatment Rule
36
Surface Water Treatment Rule
36
Surface Water Treatment Rule
36
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Surface Water Treatment Rule
36
Surface Water Treatment Rule
36
Surface Water Treatment Rule
36
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
2021(170)
Benzene
03
Endrin
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Endrin
03
1,2-Dichloroethane
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
1,2-Dichloroethane
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
Toluene
03
Toluene
03
Benzene
03
Styrene
03
Beryllium, Total
03
Beryllium, Total
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
Ethylbenzene
03
Mercury
03
Mercury
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Picloram
03
Picloram
03
Styrene
03
Ethylbenzene
03
Toxaphene
03
OXAMYL
03
Toxaphene
03
BHC-GAMMA
03
CHLOROBENZENE
03
2,3,7,8-TCDD
03
2,3,7,8-TCDD
03
CHLOROBENZENE
03
BHC-GAMMA
03
Glyphosate
03
Glyphosate
03
Pentachlorophenol
03
Pentachlorophenol
03
Chlordane
03
Chlordane
03
Dalapon
03
Dalapon
03
Diquat
03
Diquat
03
Fluoride
03
Fluoride
03
Endothall
03
Methoxychlor
03
Methoxychlor
03
OXAMYL
03
Nitrate
03
Nitrate
03
2,4-D
03
CYANIDE
03
Thallium, Total
03
Thallium, Total
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
CYANIDE
03
Endothall
03
Simazine
03
Barium
03
Barium
03
Carbofuran
03
Carbofuran
03
Simazine
03
Asbestos
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Dinoseb
03
Dinoseb
03
Arsenic
03
Arsenic
03
LASSO
03
LASSO
03
Heptachlor
03
Selenium
03
Selenium
03
2,4-D
03
Nitrite
03
Heptachlor
03
Heptachlor epoxide
03
Nitrite
03
Trichloroethylene
03
Xylenes, Total
03
Xylenes, Total
03
Heptachlor epoxide
03
2,4,5-TP
03
Cadmium
03
Cadmium
03
Trichloroethylene
03
Nickel
03
Nickel
03
2,4,5-TP
03
HEXACHLOROBENZENE
03
Tetrachloroethylene
03
Tetrachloroethylene
03
HEXACHLOROBENZENE
03
Benzo(a)pyrene
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
Antimony, Total
03
Antimony, Total
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
Benzo(a)pyrene
03
1,2-DIBROMO-3-CHLOROPROPANE
03
1,2-DIBROMO-3-CHLOROPROPANE
03
Gross Alpha, Excl. Radon and U
03
Atrazine
03
Atrazine
03
Chromium
03
Chromium
03
Asbestos
03
1,2,4-Trichlorobenzene
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Combined Uranium
03
Combined Radium (-226 and -228)
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Combined Radium (-226 and -228)
03
1,2,4-Trichlorobenzene
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
4F
E. COLI
34
Public Notice
75
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
2A
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
4F
Revised Total Coliform Rule
2B
Bromate
27
Revised Total Coliform Rule
3A
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Bromate
27
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
4F
Revised Total Coliform Rule
3A
How Does This Compare?
AUBURN (17922) has 450 recorded violations, including 17 health-based. 13 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
Activated Carbon Filter
Excellent for removing chlorine, chloramine, and disinfection byproducts like THMs and HAAs. Available as pitcher filters, countertop, or under-sink units.
Targets:THMs, HAAs, Chlorine, Chloramine, Taste & Odor
Look for:NSF/ANSI 42 & 53 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.